Zobrazeno 1 - 10 of 46 pro vyhledávání: '"Alan R. Hull"'
2
Living kidney donation: A survey of professional attitudes and practices
Autor: J. Thomas Rosenthal, Carol L. Beasley, Alan R. Hull
Publikováno v: American Journal of Kidney Diseases. 30:549-557
Living donation is an option for meeting the needs of patients with end-stage renal disease. We surveyed kidney transplant professionals to understand their attitudes, opinions, and practices regarding living donation and to generate a rough estimate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32144ea3231fac3817e55796dd918e59
https://doi.org/10.1016/s0272-6386(97)90315-2
Zobrazit plný text záznamu
3
Recommended Clinical Practices for Maximizing Peritoneal Dialysis Clearances
Autor: Peter Blake, John M. Burkart, David N. Churchill, John Daugirdas, Thomas Depner, Richard J. Hamburger, Alan R. Hull, Stephen M. Korbet, John Moran, Karl D. Nolph, Dimitrios G. Oreopoulos, Martin Schreiber, Robert Soderbloom
Publikováno v: Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 16:448-456
Data from the Canada-U.S.A. (CANUSA) Study have recently confirmed a long-suspected linkage between total clearance and patient survival in peritoneal dialysis (PD). Recognizing that what we have historically accepted as adequate PD simply is not, th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71e060831365d69777ebd040318fdf06
https://doi.org/10.1177/089686089601600507
Zobrazit plný text záznamu
4
The 1989 Dallas Conference on Morbidity and Mortality in Dialysis: what did we learn?
Autor: Alan R. Hull
Publikováno v: Clinical journal of the American Society of Nephrology : CJASN. 4
I will attempt to recall, as best as my memory allows, what we learned from the 1989 Dallas Conference on Morbidity and Mortality and Prescription of Dialysis. These thoughts and opinions are my remembrance in the subsequent time period and therefore
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129b1a8216dde870f0db554be3133f0c
https://pubmed.ncbi.nlm.nih.gov/19996001
Zobrazit plný text záznamu
5
Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study
Autor: Bertrand L, Jaber, Yoojin, Lee, Allan J, Collins, Alan R, Hull, Michael A, Kraus, James, McCarthy, Brent W, Miller, Les, Spry, Fredric O, Finkelstein, Bessie, Young
Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 56(3)
Clinical depression and postdialysis fatigue are important concerns for patients with kidney failure and can have a negative impact on quality of life and survival.The FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measure
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e27ccd08dc830f626f67abaf08751b1
https://pubmed.ncbi.nlm.nih.gov/20673601
Zobrazit plný text záznamu
7
Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study
Autor: Allan J. Collins, John K. Leypoldt, Bertrand L. Jaber, John Moran, Fredric O. Finkelstein, Brent W. Miller, James T. McCarthy, Alan R. Hull, Michael A. Kraus, Jiannong Liu, David T. Gilbertson, Joel D. Glickman
Publikováno v: American journal of kidney diseases : the official journal of the National Kidney Foundation. 53(2)
Background: Conventional thrice-weekly hemodialysis (HD) has limited the ability to generate further improvements in patient quality of life, morbidity, and mortality. Daily HD (DHD) offers the promise of providing clinical and economic benefits. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc2f3be9ebb4d4bc2bec41670caa2da
https://pubmed.ncbi.nlm.nih.gov/18823688
Zobrazit plný text záznamu
9
A time for rediscovery: chronic hemofiltration for end-stage renal disease
Autor: James T. McCarthy, John K. Leypoldt, Ricardo Correa-Rotter, Bertrand L. Jaber, John Moran, Alan R. Hull, G.A. Posen
Publikováno v: Seminars in dialysis. 16(3)
Provision of maintenance renal replacement therapy (MRRT) is becoming increasingly challenging. The number of patients requiring MRRT is growing rapidly, while the number of nephrologists, nurses, and other staff available to provide therapy is not i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4003ea801aeba11582bf1cca37228691
https://pubmed.ncbi.nlm.nih.gov/12753678
Zobrazit plný text záznamu
10
L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Autor: Theodore I, Steinman, Allen R, Nissenson, Richard J, Glassock, John, Dickmeyer, William D, Mattern, Thomas F, Parker, Alan R, Hull
Publikováno v: Nephrology newsissues. 17(5)
Careful review of all available clinical trials of L-carnitine leads to the conclusion that there is insufficient evidence to support the routine use of L-carnitine for any indication in dialysis patients. The literature suffers from a lack of adequa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8692fbb2109cf1eaa205fda5363bfede
https://pubmed.ncbi.nlm.nih.gov/12847956
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje